Amneal Pharmaceuticals Inc Stock Ownership - Who owns Amneal Pharmaceuticals?

Insider buying vs selling

Have Amneal Pharmaceuticals Inc insiders been buying or selling?
Deborah M. AutorDirector2024-05-1723,447$6.73
Deborah M. AutorDirector2024-05-1614,553$6.76
Tasos KonidarisExecutive Vice President CFO2024-03-1230,790$5.31
Nikita ShahExecutive Vice President2024-03-0318,153$5.47
Andrew S. BoyerExecutive Vice President2024-03-0324,897$5.47
Andrew S. BoyerExecutive Vice President2024-03-0319,665$5.47
Jason B. DalySVP Chief Legal Officer2024-03-0310,864$5.47
Jason B. DalySVP Chief Legal Officer2024-03-037,166$5.47
Tasos KonidarisExecutive Vice President CFO2024-03-0320,126$5.47
Tasos KonidarisExecutive Vice President CFO2024-03-0315,897$5.47

1 of 2

AMRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AMRX insiders and whales buy or sell their stock.

AMRX Shareholders

What type of owners hold Amneal Pharmaceuticals Inc stock?
Tushar Bhikhubhai Patel34.72%107,156,418$761.88MInsider
Gautam Patel15.68%48,394,386$344.08MInsider
Dipan Patel8.72%26,905,073$191.30MInsider
Dipan 1. Patel8.72%26,905,073$191.30MInsider
Chintu Patel8.19%25,265,818$179.64MInsider
Chirag K. Patel7.06%21,781,986$154.87MInsider
Fosun International Ltd5.96%18,407,656$130.88MInsider
Ambient Impact Hk Ltd5.33%16,438,356$116.88MInsider
Tpg Group Holdings Sbs Advisors Inc5.25%16,213,367$115.28MInsider
Vanguard Group Inc4.45%13,728,233$97.61MInstitution

1 of 3

AMRX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AMRX25.00%75.00%Net SellingNet Selling
BHC71.33%28.67%Net SellingNet Buying
AMPH49.17%50.83%Net BuyingNet Buying

Amneal Pharmaceuticals Stock Ownership FAQ

Who owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals (NASDAQ: AMRX) is owned by 35.04% institutional shareholders, 105.09% Amneal Pharmaceuticals insiders, and 0.00% retail investors. Tushar Bhikhubhai Patel is the largest individual Amneal Pharmaceuticals shareholder, owning 107.16M shares representing 34.72% of the company. Tushar Bhikhubhai Patel's Amneal Pharmaceuticals shares are currently valued at $750.09M.

If you're new to stock investing, here's how to buy Amneal Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.